Abbott Laboratories (NY:ABT)

97.50 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

58 59 Next >

These S&P500 stocks are gapping in today's session ↗

October 15, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session.

Via Chartmill

1 No-Brainer Dividend Stock to Buy and Hold Forever ↗

October 15, 2025

This is about as safe as a dividend can be.

Via The Motley Fool

Abbott Tightens Annual Sales Forecast As Q3 Sales Miss Expectations ↗

October 15, 2025

Abbott stock fell as Q3 sales missed estimates and 2025 earnings guidance was narrowed despite solid growth in medical devices.

Via Benzinga

Topics Earnings

Abbott Labs Skids On Mixed Third-Quarter Report, But One Segment Shined ↗

October 15, 2025

Notably, the company reaffirmed its sales guidance and the midpoint of its earnings outlook.

Via Investor's Business Daily

What's going on in today's pre-market session: S&P500 movers ↗

October 15, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

Abbott Laboratories (NYSE:ABT) Trims 2025 Outlook After Q3 Earnings ↗

October 15, 2025

Abbott Labs Q3 2025 results met EPS views, but trimmed full-year guidance. Sales grew 6.9% as the healthcare giant navigates a complex market.

Via Chartmill

Abbott Laboratories (NYSE:ABT) Reports Q3 In Line With Expectations

October 15, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 6.9% year on year to $11.37 billion. Its non-GAAP profit of $1.30...

Via StockStory

Stock Market Today: Nasdaq, Dow Jones Futures Rise, Bank Of America, Morgan Stanley, Abbott In Focus—Analyst Warns US 'Going Broke Slowly' ↗

October 15, 2025

U.S. stock futures advanced on Wednesday following Tuesday’s mixed close. Futures of major benchmark indices were higher.

Via Benzinga

Topics Stocks

Earnings Scheduled For October 15, 2025 ↗

October 15, 2025

Via Benzinga

Dow Jumps Over 200 Points Following Strong Bank Earnings: Investor Fear Eases Slightly, But Greed Index Remains In 'Fear' Zone ↗

October 15, 2025

Dow Jones gains, but trade tensions limit enthusiasm. Wells Fargo, Citi, JPMorgan, and Goldman Sachs beat expectations.

Via Benzinga

Topics Stocks World Trade

Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Wednesday ↗

October 15, 2025

US stock futures higher, BAC, PZZA, MS expected to report earnings, ASML reports better-than-expected bookings, ABT to report earnings.

Via Benzinga

A Look Ahead: Abbott Laboratories's Earnings Forecast ↗

October 14, 2025

Via Benzinga

Abbott Laboratories (ABT) Q3 Earnings Report Preview: What To Look For

October 13, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be reporting earnings this Wednesday morning. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Abbott Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

October 13, 2025

Via Benzinga

Dow Jones Soars on Trump's Tariff Remarks, Signaling Market Volatility Amidst Trade Policy Shifts

October 13, 2025

New York, NY – October 13, 2025 – The Dow Jones Industrial Average has experienced significant upward momentum in recent months, notably jumping by hundreds of points on multiple occasions in early...

Via MarketMinute

Topics Economy Government Stocks

A Congress Member Sold Up To $300K In A.O. Smith Stock: Here's What You Need To Know ↗

October 08, 2025

Via Benzinga

Retail Investors' Top Stocks With Earnings This Week: Fastenal, ASML, TSMC And More ↗

October 13, 2025

Retail investors are preparing for the kick-off of the Q3 earnings season, with big banks and other top stocks reporting this week.

Via Benzinga

2 Cash-Producing Stocks Worth Your Attention and 1 We Avoid

October 08, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Forecasting The Future: 12 Analyst Projections For Abbott Laboratories ↗

October 07, 2025

Via Benzinga

3 Dividend Stocks to Double Up On Right Now ↗

October 07, 2025

The time is right for buying more of these great dividend stocks.

Via The Motley Fool

Topics Economy Energy

10 Health Care Stocks Whale Activity In Today's Session ↗

October 06, 2025

Via Benzinga

Breakthrough in Alzheimer’s Diagnostics: University of Liverpool Unveils Low-Cost, Handheld AI Blood Test

October 06, 2025

In a monumental stride towards democratizing global healthcare, researchers at the University of Liverpool have announced the development of a pioneering low-cost, handheld, AI-powered blood test...

Via TokenRing AI

Topics Artificial Intelligence

Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience

October 02, 2025

On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

2 Profitable Stocks to Consider Right Now and 1 We Find Risky

October 02, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

1 Top ETF I Wouldn't Hesitate to Invest $1,000 Into Right Now ↗

September 29, 2025

This fund makes it easy to invest in the top dividend stocks.

Via The Motley Fool

Topics ETFs Stocks

Abbott India Limited: A Deep Dive into its Robust Forecast and Valuation Outlook Amidst a Thriving Indian Pharma Market

September 27, 2025

Mumbai, India – September 27, 2025 – Abbott India Limited (NSE: ABBOTINDIA), a prominent player in the Indian pharmaceutical sector, is exhibiting a robust financial trajectory and a promising...

Via MarketMinute

Topics Economy Intellectual Property

Abbott Laboratories (NYSE:ABT) Passes the Caviar Cruise Quality Investing Screen ↗

September 27, 2025

Discover Abbott Laboratories (ABT), a top Caviar Cruise screen pick. This healthcare leader excels in profitability, financial health, and cash flow, making it a strong long-term quality investment.

Via Chartmill

September 25, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

Topics Retirement

Abbott Laboratories (NYSE:ABT) Presents a Technical Breakout Setup for Investors ↗

September 24, 2025

Abbott Laboratories (ABT) is a technical breakout candidate, showing a strong uptrend and a perfect consolidation setup, suggesting a potential upward move.

Via Chartmill

The Magnificent 7 Boom Just Triggered A Dot-Com Era Warning ↗

September 23, 2025

The Magnificent Seven tech giants are now worth $21 trillion—8x more than top health care stocks, echoing dot-com bubble extremes.

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

58 59 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.